CHI3L1 and Hepatic fibrosis: Because most hemodialysis patients present with systemic inflammation/fibrosis from nonhepatic origins, all serological indices targeting ECM dynamics, including FibroTest, hyaluronic acid, and YKL-40, are not recommended in clinical practice to predict the stage of hepatic fibrosis in hemodialysis patients with HCV infection.